Amicus Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Amicus Therapeutics (Nasdaq: FOLD) announced that its CEO, John F. Crowley, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 8:20 a.m. ET. A live audio webcast of the presentation will be available on the company’s investor website.

Amicus Therapeutics focuses on developing innovative therapies for rare metabolic diseases, driven by a commitment to patient care. For insights, visit the company's website.

CRANBURY, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the 39^th Annual J.P. Morgan Healthcare Conference, being held virtually on Tuesday, January 12, 2021 at 8:20 a.m. ET.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Director, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Communications
dmoore@amicusrx.com
(609) 662-5079

FOLD–G

FAQ

When will Amicus Therapeutics present at the J.P. Morgan Healthcare Conference?

Amicus Therapeutics will present on January 12, 2021, at 8:20 a.m. ET.

How can I listen to the Amicus Therapeutics presentation?

The presentation will be accessible via a live audio webcast on the investors section of the Amicus Therapeutics corporate website.

What is the focus of Amicus Therapeutics?

Amicus Therapeutics is dedicated to discovering and developing novel medicines for patients with rare metabolic diseases.

What is the stock symbol for Amicus Therapeutics?

The stock symbol for Amicus Therapeutics is FOLD.

Who is the CEO of Amicus Therapeutics?

John F. Crowley is the Chairman and CEO of Amicus Therapeutics.